Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/49/1e/7e/491e7ef8-6996-a544-5e98-e0cc06aa0149/mza_10921017996814677989.png/600x600bb.jpg
touchPODCAST
touchpodcast
517 episodes
1 week ago
Show more...
Science
RSS
All content for touchPODCAST is the property of touchpodcast and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Show more...
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/49/1e/7e/491e7ef8-6996-a544-5e98-e0cc06aa0149/mza_10921017996814677989.png/600x600bb.jpg
Navigating the evolving role of immunotherapy in advanced endometrial carcinoma
touchPODCAST
43 minutes 31 seconds
3 months ago
Navigating the evolving role of immunotherapy in advanced endometrial carcinoma
touchPANEL DISCUSSION for touchONCOLOGY Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-related adverse events through practical monitoring strategies. The experts Prof. Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France Prof. Nicoletta Colombo, University of Milan-Bicocca, Milan, Italy Dr Brian Slomovitz, Mount Sinai Medical Center, Miami, FL, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.This activity is jointly provided by USF Health and touchIME.touchIME is an EBAC® accredited provider.For further information visit our website: www.touchONCOLOGY.com 
touchPODCAST